Critical

Refractory anaphylaxis — adrenaline infusion (adult)

Anaphylaxis not responding to two or more IM adrenaline doses · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Refractory anaphylaxis is persistent respiratory/cardiovascular compromise despite two appropriate IM adrenaline doses and fluid resuscitation. It mandates escalation to a low-dose IV adrenaline infusion with critical-care involvement rather than repeated large IV boluses, which risk arrhythmia and myocardial ischaemia.

Figures & algorithms

Recognition & management
Recognition & management

Red flags

  • Falling SpO2 or rising CO2 signalling impending respiratory arrest
  • Progressive tongue/laryngeal oedema with stridor
  • Persistent hypotension despite adrenaline infusion and 2 L fluid
  • New ECG ischaemia or arrhythmia during adrenaline therapy
  • Reduced conscious level

Assessment

Differential diagnosis

  • Adrenaline under-dosing or delayed administration
  • Severe asthma / acute bronchospasm
  • Cardiogenic or distributive (septic) shock
  • Beta-blocker or ACE-inhibitor interference with response
  • Tension pneumothorax or pulmonary embolism mimicking shock

Investigations

  • Continuous ECG, SpO2, non-invasive then arterial BP monitoring
  • Serial mast cell tryptase (at resuscitation, 1-2 h, and >24 h baseline)
  • Venous/arterial blood gas with lactate
  • 12-lead ECG to exclude ischaemia/arrhythmia
  • Bedside echo if shock persists (exclude cardiogenic cause / assess filling)

Management

  • Confirm high-flow oxygen 15 L/min, remove trigger, lie flat with legs raised (sit up if airway swelling/respiratory distress)
  • Give repeat IM adrenaline 500 mcg every 5 min while preparing infusion; call for critical care / anaesthetics early
  • Establish large-bore IV access and give rapid crystalloid bolus 500-1000 mL, repeat to total 1-2 L guided by response
  • Start IV adrenaline infusion titrated to effect once two IM doses have failed
  • Add a second vasopressor/inotrope (noradrenaline, metaraminol or vasopressin) if shock persists despite adrenaline and fluids
  • Give glucagon if the patient takes beta-blockers and is not responding
  • Treat refractory bronchospasm with nebulised salbutamol and consider IV magnesium
  • Secure definitive airway early if progressive angioedema or exhaustion; prepare for front-of-neck access
  • Admit to ICU/HDU for monitored observation and taper infusion slowly

Drugs & doses

Adrenaline IM — 500 mcg (0.5 mL 1:1000), repeat every 5 min
Adrenaline IV infusion — 1 mg in 100 mL 0.9% saline (10 mcg/mL), start 0.5-1 mL/kg/hour (approx 0.05-0.1 mcg/kg/min), titrate to response (critical-care supervised)
Glucagon — 1-2 mg IV every 5 min, then infusion 5-15 mcg/min for beta-blocked patients
Noradrenaline — 0.05-0.5 mcg/kg/min IV infusion via central access, titrated
Magnesium sulfate — 2 g IV over 20 min for refractory bronchospasm
Salbutamol — 5 mg nebulised, repeated/back-to-back

Disposition

Admit to ICU/HDU for monitored weaning of the infusion, minimum 6-12 h observation after stabilisation, and specialist allergy follow-up before discharge.

Complications & pitfalls

  • Adrenaline-induced tachyarrhythmia or Takotsubo/myocardial ischaemia
  • Cardiac arrest from hypoxia or profound vasodilation
  • Pulmonary oedema from over-aggressive fluid resuscitation
  • Biphasic reaction during recovery
  • Hypoxic-ischaemic brain injury

Exam pearls

  • Refractory anaphylaxis is an infusion problem, not a bolus problem — avoid repeated undiluted IV adrenaline boluses on the ward
  • Always ask about beta-blockers/ACE-inhibitors — they predict poor response and guide glucagon use
  • Antihistamines and steroids do not treat shock and must not delay adrenaline
  • A normal initial tryptase does not exclude anaphylaxis; serial samples are more informative

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.